Treatment with the immunotherapy dostarlimab showed promising results in a small trial of more than a dozen rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. CNN’s Erin Burnett speaks to Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center.
A sweeping new report from the American Cancer Society suggests cancer will likely be the leading cause of early deaths worldwide by 2050, with cases projected to rise by 74%.
“This is because of population aging and growth,” said Ahmedin Jemal, senior vice president of the Surveillance & Health Equity Science Department of the American Cancer Society and the chief editor of the report.
In 2022, there were about 19 million new cancer cases worldwide. Continue reading
Your heart health is one of the most crucial components of your overall wellbeing. A healthier heart makes a healthier body, and your diet, exercise, and lifestyle choices all play significant roles. While a balanced diet should provide essential nutrients, certain supplements could help fuel your body with everything it needs to reduce inflammation and regulate critical functions like blood pressure and heart rhythm, boosting your cardiovascular health.
Dr. Jeremy London, a cardiac surgeon, highlighted three supplements that he strongly recommends for daily heart health on TikTok. These include Coenzyme Q10 (CoQ10), Omega-3 fatty acids, and Magnesium. Each of these can help your heart stay in great shape, supporting functions from energy production to inflammation control and electrolyte balance. Read on to learn more about the benefits of each. Continue reading
New research reveals the Inflation Reduction Act’s $2,000 cap may not help most Medicare beneficiaries as insurers raise drug costs and deductibles. Image (c) ConsumerAffairs
A core promise of the Inflation Reduction Act (IRA), signed by President Biden in 2022, was to lower the cost of prescription medications for Americans, particularly older adults on Medicare. But new research suggests the reality may be more complicated — and costlier — for most beneficiaries. Continue reading
Nearly 20,000 patients at Memorial Sloan Kettering could lose access to critical care because of a contract battle between the renowned cancer hospital and health insurance behemoth UnitedHealthcare.
The two sides have until the end of June to hash out a new deal over reimbursement rates — but are trading blame while patients, many in need of lifesaving care, anxiously wait to see if they will keep in-network treatment.
Patient Lee Kassler, of Plainview, Long Island, said he was in “disbelief” and “shocked” when he found out that he could lose care on July 1 if the Manhattan hospital and health insurance company don’t reach an agreement by June 30.
“Full of anxiety, full of stress, saddened, angry, worried, just a whole host of emotions that I was faced with when I was diagnosed with cancer,” Kassler, who has had a rare, incurable gastric cancer since 2022, told The Post Friday. Continue reading
Patient Beware! Journal of the American Medical Association admits doctors are third leading cause of death in the U.S. Quackwatch is major proponent of AMA and conventional medicine.
Last year JAMA (Journal of the American Medical Association) admitted that doctors are the third leading cause of death in the U.S. Personally, I think the statistics are on the low side. I wouldn’t be surprised if they”re the leading cause (remember that old saying, “doctors bury their mistakes.” And those mistakes often don”t make it into the records. I’ve seen it.)
I blame this sad state of affairs on the fact the AMA is an arrogant government-backed guild dedicated to protecting doctors’ incomes, status and professional and political power at the expense of peoples’ health and lives. It doesn’t get rid of bad doctors and attempts to prevent competition. Without competition, the status quo becomes frozen. This means protecting the status quo becomes more important than protecting people (years ago doctors use to make house calls. Guess what happened to that?) Protecting the status quo is one of those bad laws of human nature. Continue reading
Photo Illustration by Vartika Sharma
The moment she heard that her mother, then 67, had advanced breast cancer, Stacie Dusetzina began hunting for potential treatments. A cancer policy researcher at Vanderbilt University, Dusetzina knew the go-to drug in many cases was Pfizer Inc.’s Ibrance. She learned it might cost her mother, who lived on a fixed income, around $10,000 out of pocket annually.
Medicare, required by law to cover cancer treatment, would have paid much of the rest of the cost. At the time, in 2020, the pill listed for a jaw-dropping $160,000 a year, rising more recently to $214,000. Continue reading
June 17, 2025: cancer, Cancer, CANCER!
Woman, 27, Diagnosed With Blood Cancer Shares 7 Symptoms She Overlooked
A woman who was diagnosed with stage 2 Hodgkin lymphoma has shared the symptoms that led to her diagnosis, revealing she had blood cancer.
According to Mayo Clinic, Hodgkin lymphoma is a type of cancer that affects the lymphatic system, which helps the body fight germs and diseases. It’s a group of blood cancers that form in the white blood cells called lymphocytes.
Stage 2 indicates the cancer is found in two or more groups of lymph nodes… (Continue to full article)
The above graphic shows the seven factors scientists say raise the risk of colon cancer in younger men
‘I’m a Gastroenterologist — These Are the 4 Colon Cancer Signs You Should Never, Ever Ignore’
Colon cancer rates are surging worldwide, especially among younger and relatively healthy people , making it more important than ever to know the signs of the disease and screen for it sooner. Early-onset colorectal cancer occurs in patients between 25 and 49 years old, and the current rate in most western and industrialized countries is 14 to 17 cases per 100,000 individuals.
“Colorectal cancer is the third-leading cause of cancer-related deaths in men and the fourth leading cause in women, according to the American Cancer Society… (Continue to full article)
Common Cooking Oils Linked to Breast Cancer Growth
Scientists have discovered a mechanism connecting omega-6 fatty acids to aggressive breast cancer progression.
A type of fat found in commonly used seed oils has been linked to faster growth of one of the most aggressive and difficult-to-treat forms of breast cancer.
A recent study found that high linoleic acid consumption activated a critical growth pathway in cancer cells… (Continue to full article)
Bladder Cancer: Symptoms to Look Out for and When to See a Doctor
A “game-changer” study claims bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to survive.
Patients with advanced (muscle-invasive) bladder cancer had significantly less risk of cancer progressing or returning when treated with durvalumab, and were more likely to still be alive two years after treatment.
Experts from the University of Sheffield and Barts Cancer Institute at Queen Mary University of London included 1,063 patients with operable bladder cancer in their study… (Continue to full article)
Symptoms of Bladder Cancer in Women
Symptoms of bladder cancer can include issues that relate to passing urine, such as blood in urine and changes in the frequency of urination.
Overall, bladder cancer is more common in males than in females. About 9 in 10Trusted Source bladder cancer cases occur after the age of 55, with an average age of onset of about 73.
Blood in the urine is a common early sign, which many females may mistake for other issues or doctors may misdiagnose. This can lead to later-stage or more advanced cancer.
This article reviews the symptoms that females with bladder cancer may experience. It will also explain risk factors, prevalence, and the outlook for bladder cancer
Are Uterine Cancer and Endometrial Cancer the Same?… (Continue to full article)
Phenazopyridine — sold under various brand names including Azo, Pyridium, Prodium, Pyridiate, Baridium, and Uricalm — is available over the counter (OTC) in the US and UK at lower strengths and by prescription at higher strengths.
It works by numbing the lining of the urinary tract, which helps to lessen the symptoms of urinary tract infections (UTIs), which include burning, irritation, and discomfort, as well as frequent and urgent urination.
But now experts are warning the drug could cause cancer based on early evidence from animal studies. Continue reading
The FDA is forcing Pfizer and Moderna to use expanded warning labels about the risks of heart damage tied to Covid vaccines.
The shots previously included warning labels about the rare risks of myocarditis, inflammation of the heart muscle, and pericarditis, inflammation of the sac-like lining surrounding the heart.
The new labels will expand that warning to certain age groups — specifically males aged 16 to 25 who appear to be at the highest risk of the rare complication. Continue reading
What if everything you thought you knew about anxiety – or ADHD – was missing the bigger picture? In a powerful episode of The Mel Robbins Podcast , Mel sits down with psychiatrist Dr. Tracy Marks to unpack the deep, often misunderstood connection between these two conditions. What she shared can shift not just how you understand your own mental health, but how you support the people you love. Continue reading
1911, May 15
The Supreme Court of the U.S. finds John Rockefeller and his Trust guilty of corruption, illegal business practices and racketeering. As a result of this decision, the entire Rockefeller Standard Oil-Trust, the world’s largest corporation of its time, was sentenced to be dismantled. But Rockefeller was already above the Supreme Court and did not care about this decision. Continue reading
Illustration by Deena So’oteh
If health care industry corruption and criminality were a city skyline, it would be booming, with tower cranes and half-built skyscrapers in every direction. Among the downtown giants at the center would stand Johnson & Johnson, an iconic U.S. company whose villainy receives a just and overdue accounting in Gardiner Harris’s No More Tears: The Dark Secrets of Johnson & Johnson.
The book is an investigative demolition job in the best tradition of muckraking exposés and should find a sizable and receptive audience at a moment when public sentiment toward our corporate health care system ranges between Ralph Nader and Luigi Mangione. Harris, a former reporter for The New York Times, spent years digging into the company’s past and conducted hundreds of interviews, but the most damning evidence in the book comes from internal documents that have surfaced during decades of lawsuits against the company’s long record of public endangerment. Continue reading